Etropal AD (BUL:ETR)

Market Cap	22.06M -22.6%
Revenue (ttm)	20.24M +28.5%
Net Income	324.00K +272.4%
EPS	0.06 +272.4%
Shares Out	5.00M
PE Ratio	69.39
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	70
Average Volume	613
Open	2.300
Previous Close	2.300
Day's Range	2.300 - 2.300
52-Week Range	1.936 - 2.340
Beta	0.05
RSI	70.91
Earnings Date	May 29, 2026

About Etropal AD

Etropal AD engages in the development, manufacture, and sale of disposable medical devices for dialysis in Bulgaria. The company offers capillary dialyzers; arterial-venous blood line sets; procedure kits; and arterial-venous fistula needles. Etropal AD was founded in 1976 and is headquartered in Etropole, Bulgaria. Etropal AD is a subsidiary of Synthetica AD.

• Industry: Surgical and Medical Instruments and Apparatus
• Founded: 1976
• Employees: 101
• Stock Exchange: Bulgarian Stock Exchange
• Ticker Symbol: ETR

Financial Performance

In 2025, Etropal AD's revenue was 20.24 million, an increase of 28.55% compared to the previous year's 15.75 million. Earnings were 324,000, an increase of 272.41%.